News Formal

Coronavirus treatment: Gilead says positive data on remdesivir coming - Business Insider

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 11 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 51%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Gilead's coronavirus treatment remdesivir just succeeded in a crucial study, raising hopes for a first COVID-19 drug

Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification.

The antiviral drug remdesivir is being tested in several ongoing trials of COVID-19 patients. Gilead stated that one of these studies, run by the US National Institutes of Health, shows the drug works.

 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 729. in KR

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Coronavirus research: flaws in trials for remdesivir, chloroquine - Business Insider'We have no reliable data' on potential coronavirus treatments, one researcher said. Here's how that could change over the next few weeks.
출처: BusinessInsider - 🏆 729. / 51 더 많은 것을 읽으십시오 »

Coronavirus: EU rewrote coronavirus report after pressure by China - Business InsiderReferences to a Chinese campaign of 'global disinformation' about the coronavirus were removed before publication. China wins again! Shame on EU !
출처: BusinessInsider - 🏆 729. / 51 더 많은 것을 읽으십시오 »

Coronavirus antibody treatments: Eli Lilly, Regeneron, GSK, Amgen - Business Insider4 top drugmakers are studying the body's own efforts to fight off viruses as they race to find a COVID-19 treatment that could be ready by the fall Yaaaaay Yeah seriously, I can't stop itching all over!!!!
출처: BusinessInsider - 🏆 729. / 51 더 많은 것을 읽으십시오 »